tm logo
SNAPAAV
FORMALIZED

on 12 Jun 2024

Last Applicant/ Owned by

NATIONAL RESILIENCE INC.

3115 Merryfield Row, Suite 200San Diego, CA 92121

US

Serial Number

2332238 filed on 12th Jun 2024

Correspondent Address

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

SNAPAAV

Trademark usage description

custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, Read More

Classification Information


Class [040]
Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing platform for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology


Classification kind code

12

Class [042]
Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services; biotechnology research and development; scientific, pharmaceutical, and medical research services relating to biological treatment and bioproduction; design and development of technology platforms relating to biological treatment for use in the manufacture of pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; provision of information relating to research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms; development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services relating to the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins


Classification kind code

12

Mark Details


Serial Number

2332238

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 287
on 27th Jun 2024
Pre-Assessment Letter Sent
Submitted for opposition 30
on 12th Jun 2024
Filed
Submitted for opposition 1
on 12th Jun 2024
Created
Submitted for opposition 31
on 12th Jun 2024
Formalized